中文網
Taipei
Tue, May 17, 2022
12:52
mostly cloudy
23°C
CONNECT WITH US
Related company info
Jay Liu, Taipei; Eifeh Strom, DIGITIMES
Friday 22 October 2021
  • APEX Medical
  • Performance
    The company's stock price closed at NT$28.1 on the TSE on Friday, May 13, 2022.
    The company has reported consolidated revenues of NT$201 million for April 2022, representing a 4.5% drop on month and 14.5% increase on year.
    For the fourth quarter of 2021, the company totaled NT$618 million in consolidated revenues, up 3.3% sequentially and up 11.7% on year.
    Brief

    Full name: APEX Medical

    Chinese name: 雃博股份有限公司

    Short name: Apex

    Stock code: 4106

    Tax ID: 23632773

    Market: TSE

    Established: 17 Mar 1990

    Paid in capital: NT$833.86 million

    Listed on TSE: 8 Nov 2004

    Listed on OTC: 22 Jan 2002

    Listed on ESB: 2 Jan 2002

    Public since: 19 Jul 1999

    Website: cht.apexmedical.com.tw

  • Latest stock
    Apex [4106] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    16-May 1,601 1,005 45,820,956 28.40 29.30 27.85 28.65+0.55+1.96% 28.60 28.65
    13-May 1,757 1,076 48,945,291 27.60 28.30 27.25 28.10+0.65+2.37% 28.05 28.10
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Apr 2021 - Apr 2022 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Apr-22

    201

    (4.5%)

    14.5%

    797

    5.3%

    Mar-22

    211

    9.2%

    (11.9%)

    595

    2.5%

    Feb-22

    193

    0.5%

    19.2%

    385

    12.6%

    Jan-22

    192

    (4.8%)

    6.6%

    192

    6.6%

    Dec-21

    202

    6.5%

    0.5%

    2,374

    18.4%

    Nov-21

    189

    (16.7%)

    5.2%

    2,172

    20.4%

    Oct-21

    227

    (3.3%)

    30.1%

    1,983

    22%

    Sep-21

    235

    30.7%

    13.8%

    1,756

    21.1%

    Aug-21

    180

    (2.2%)

    24.1%

    1,521

    22.3%

    Jul-21

    184

    (5.3%)

    5.9%

    1,341

    22%

    Jun-21

    194

    (6.1%)

    11.7%

    1,157

    25.1%

    May-21

    207

    17.6%

    9.6%

    963

    28.2%

    Apr-21

    176

    (26.4%)

    20.5%

    757

    34.4%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, May 2022

    Apex: Consolidated revenues, 4Q20 - 4Q21 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    4Q-21

    618

    3.3%

    11.7%

    2,374

    18.5%

    3Q-21

    598

    3.8%

    14%

    1,756

    21.1%

    2Q-21

    576

    (0.8%)

    13.4%

    1,157

    25.1%

    1Q-21

    581

    4.9%

    39.3%

    581

    39.3%

    4Q-20

    554

    5.5%

    7.2%

    2,004

    (1.6%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, May 2022

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 4Q20 - 4Q21 (NT$k)

    Item

    4Q-2021

    3Q-2021

    2Q-2021

    1Q-2021

    4Q-2020

    Current assets

    1,588,014

    1,571,775

    1,569,157

    1,469,606

    1,405,183

    Intangible assets

    668,069

    671,722

    689,911

    701,977

    701,672

    Non-current assets

    1,552,403

    1,546,030

    1,582,452

    1,609,352

    1,641,226

    Assets

    3,140,417

    3,117,805

    3,151,609

    3,078,958

    3,046,409

    Current liabilities

    873,877

    805,574

    773,474

    707,845

    709,855

    Non-current liabilities

    202,250

    232,625

    245,479

    251,087

    230,271

    Liabilities

    1,076,127

    1,038,199

    1,018,953

    958,932

    940,126

    Stockholders' equity

    2,064,290

    2,079,606

    2,132,656

    2,120,026

    2,106,283

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, May 2022

    Apex: Consolidated income statement, 4Q20 - 4Q21 (NT$k)

    Item

    4Q-2021

    3Q-2021

    2Q-2021

    1Q-2021

    4Q-2020

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

    0

     

     

     

    576,441

     

    580,866

     

    0

     

    Operating revenue

    618,333

     

    598,415

     

    576,441

     

    580,866

     

    553,793

     

    Gross profit (loss) from operations

    243,185

     

    248,590

     

    249,786

     

    245,391

     

    217,793

     

    Operating expenses

    248,231

     

    214,626

     

    220,868

     

    198,904

     

    217,181

     

    Operating income (loss)

    -5,046

     

    33,964

     

    28,918

     

    46,487

     

    612

     

    Non-operating expenses and losses

    13,883

     

    12,262

     

    12,218

     

    -4,605

     

    9,122

     

    Income from continuing operations before income tax

    8,837

     

    46,226

     

    41,136

     

    41,882

     

    9,734

     

    Net income (loss)

    7,528

     

    31,182

     

    35,126

     

    29,675

     

    14,531

     

    Diluted earnings per share (NT$)

    0.1

     

    0.3

     

    0.3

     

    0.3

     

    0.1

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, May 2022

  • APEX Medical full profile
Realtime news

Taiwan notebooks - 4Q 2021

Global server revenue forecast, 2022

Global server shipment forecast, 2022

South Korea to build semiconductor ecosystem; Tianma to invest in 8.6-gen panel project; Nissan and Honda unveil EV development plans

Advanced packaging technology outlook, 2020-2026

Smart manufacturing progress of Taiwan, 2021